215 related articles for article (PubMed ID: 17067723)
1. Receptor activated bladder and spinal ATP release in neurally intact and chronic spinal cord injured rats.
Salas NA; Somogyi GT; Gangitano DA; Boone TB; Smith CP
Neurochem Int; 2007 Jan; 50(2):345-50. PubMed ID: 17067723
[TBL] [Abstract][Full Text] [Related]
2. Frequency dependence of muscarinic facilitation of transmitter release in urinary bladder strips from neurally intact or chronic spinal cord transected rats.
Somogyi GT; Zernova GV; Yoshiyama M; Yamamoto T; de Groat WC
Br J Pharmacol; 1998 Sep; 125(2):241-6. PubMed ID: 9786494
[TBL] [Abstract][Full Text] [Related]
3. Plasticity of non-adrenergic non-cholinergic bladder contractions in rats after chronic spinal cord injury.
Lai HH; Munoz A; Smith CP; Boone TB; Somogyi GT
Brain Res Bull; 2011 Aug; 86(1-2):91-6. PubMed ID: 21689735
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury.
Khera M; Somogyi GT; Kiss S; Boone TB; Smith CP
Neurochem Int; 2004 Dec; 45(7):987-93. PubMed ID: 15337297
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.
Smith CP; Gangitano DA; Munoz A; Salas NA; Boone TB; Aoki KR; Francis J; Somogyi GT
Neurochem Int; 2008 May; 52(6):1068-75. PubMed ID: 18187233
[TBL] [Abstract][Full Text] [Related]
6. Role of M2 and M3 muscarinic acetylcholine receptor subtypes in activation of bladder afferent pathways in spinal cord injured rats.
Matsumoto Y; Miyazato M; Yokoyama H; Kita M; Hirao Y; Chancellor MB; Yoshimura N
Urology; 2012 May; 79(5):1184.e15-20. PubMed ID: 22386753
[TBL] [Abstract][Full Text] [Related]
7. Change in muscarinic modulation of transmitter release in the rat urinary bladder after spinal cord injury.
Somogyi GT; Zernova GV; Yoshiyama M; Rocha JN; Smith CP; de Groat WC
Neurochem Int; 2003 Jul; 43(1):73-7. PubMed ID: 12605884
[TBL] [Abstract][Full Text] [Related]
8. Lumbosacral sensory neuronal activity is enhanced by activation of urothelial purinergic receptors.
Munoz A; Somogyi GT; Boone TB; Smith CP
Brain Res Bull; 2011 Nov; 86(5-6):380-4. PubMed ID: 21924327
[TBL] [Abstract][Full Text] [Related]
9. Influence of urothelial or suburothelial cholinergic receptors on bladder reflexes in chronic spinal cord injured cats.
Ungerer TD; Kim KA; Daugherty SL; Roppolo JR; Tai C; de Groat WC
Exp Neurol; 2016 Nov; 285(Pt B):147-158. PubMed ID: 27423814
[TBL] [Abstract][Full Text] [Related]
10. In vivo paracrine effects of ATP-induced urothelial acetylcholine in the rat urinary bladder.
Stenqvist J; Aronsson P; Carlsson T; Winder M; Tobin G
Auton Neurosci; 2020 Sep; 227():102689. PubMed ID: 32473532
[TBL] [Abstract][Full Text] [Related]
11. Increased spinal expression of c-Fos following stimulation of the lower urinary tract in chronic spinal cord-injured rats.
Callsen-Cencic P; Mense S
Histochem Cell Biol; 1999 Jul; 112(1):63-72. PubMed ID: 10461813
[TBL] [Abstract][Full Text] [Related]
12. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of tyrosine kinase (Trka, Trkb) receptor expression and phosphorylation in lumbosacral dorsal root ganglia after chronic spinal cord (T8-T10) injury.
Qiao L; Vizzard MA
J Comp Neurol; 2002 Jul; 449(3):217-30. PubMed ID: 12115676
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 release from isolated bladder strips in rats with spinal cord injury.
Masunaga K; Yoshida M; Inadome A; Iwashita H; Miyamae K; Ueda S
Int J Urol; 2006 Mar; 13(3):271-6. PubMed ID: 16643622
[TBL] [Abstract][Full Text] [Related]
15. Influence of sildenafil on the purinergic components of nerve-mediated and urothelial ATP release from the bladder of normal and spinal cord injured mice.
Chakrabarty B; Ito H; Ximenes M; Nishikawa N; Vahabi B; Kanai AJ; Pickering AE; Drake MJ; Fry CH
Br J Pharmacol; 2019 Jul; 176(13):2227-2237. PubMed ID: 30924527
[TBL] [Abstract][Full Text] [Related]
16. Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder.
Lai HH; Boone TB; Yang G; Smith CP; Kiss S; Thompson TC; Somogyi GT
Neurochem Int; 2004 Dec; 45(8):1185-93. PubMed ID: 15380628
[TBL] [Abstract][Full Text] [Related]
17. Modulation of bladder afferent signals in normal and spinal cord-injured rats by purinergic P2X3 and P2X2/3 receptors.
Munoz A; Somogyi GT; Boone TB; Ford AP; Smith CP
BJU Int; 2012 Oct; 110(8 Pt B):E409-14. PubMed ID: 22540742
[TBL] [Abstract][Full Text] [Related]
18. Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury.
Munoz A; Somogyi GT; Boone TB; Smith CP
Neurourol Urodyn; 2011 Sep; 30(7):1376-81. PubMed ID: 21509809
[TBL] [Abstract][Full Text] [Related]
19. Effects of atropine, isoproterenol and propranolol on the rabbit bladder contraction induced by intra-arterial administration of acetylcholine and ATP.
Liu SP; Horan P; Levin RM
J Urol; 1998 Nov; 160(5):1863-6. PubMed ID: 9783975
[TBL] [Abstract][Full Text] [Related]
20. Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder.
Beckel JM; Daugherty SL; Tyagi P; Wolf-Johnston AS; Birder LA; Mitchell CH; de Groat WC
J Physiol; 2015 Apr; 593(8):1857-71. PubMed ID: 25630792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
